Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1997 | 1 |
1998 | 1 |
2014 | 1 |
2022 | 1 |
2023 | 4 |
2024 | 3 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Empagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4.
N Engl J Med. 2023.
PMID: 36331190
Free PMC article.
Clinical Trial.
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
EMPA-KIDNEY Collaborative Group.
EMPA-KIDNEY Collaborative Group.
Lancet Diabetes Endocrinol. 2024 Jan;12(1):51-60. doi: 10.1016/S2213-8587(23)00322-4. Epub 2023 Dec 4.
Lancet Diabetes Endocrinol. 2024.
PMID: 38061372
Free article.
Clinical Trial.
Item in Clipboard
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
EMPA-KIDNEY Collaborative Group.
EMPA-KIDNEY Collaborative Group.
Lancet Diabetes Endocrinol. 2024 Jan;12(1):39-50. doi: 10.1016/S2213-8587(23)00321-2. Epub 2023 Dec 4.
Lancet Diabetes Endocrinol. 2024.
PMID: 38061371
Free PMC article.
Clinical Trial.
Item in Clipboard
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.
Mayne KJ, Staplin N, Keane DF, Wanner C, Brenner S, Cejka V, Stegbauer J, Judge PK, Preiss D, Emberson J, Trinca D, Dayanandan R, Lee R, Nolan J, Omata A, Green JB, Cherney DZI, Hooi LS, Pontremoli R, Tuttle KR, Lees JS, Mark PB, Davies SJ, Hauske SJ, Steubl D, Brückmann M, Landray MJ, Baigent C, Haynes R, Herrington WG; EMPA-KIDNEY Collaborative Group.
Mayne KJ, et al.
J Am Soc Nephrol. 2024 Feb 1;35(2):202-215. doi: 10.1681/ASN.0000000000000271. Epub 2023 Dec 12.
J Am Soc Nephrol. 2024.
PMID: 38082486
Free PMC article.
Clinical Trial.
Item in Clipboard
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
3C Study Collaborative Group; Haynes R, Harden P, Judge P, Blackwell L, Emberson J, Landray MJ, Baigent C, Friend PJ.
3C Study Collaborative Group, et al.
Lancet. 2014 Nov 8;384(9955):1684-90. doi: 10.1016/S0140-6736(14)61095-3. Epub 2014 Jul 28.
Lancet. 2014.
PMID: 25078310
Clinical Trial.
Item in Clipboard
Preoperative induction with tacrolimus does not have a detrimental effect on primary graft function in adult cadaveric renal transplantation.
Morris-Stiff G, Singh J, Balaji V, Ostrowski K, Webley Y, Moore R, Lord R, Jurewicz WA.
Morris-Stiff G, et al. Among authors: webley y.
Transplant Proc. 1998 Jun;30(4):1230-1. doi: 10.1016/s0041-1345(98)00221-8.
Transplant Proc. 1998.
PMID: 9636499
Clinical Trial.
No abstract available.
Item in Clipboard
Conversion from cyclosporine Sandimmune to cyclosporine Neoral in the stable renal transplant population.
Griffin PJ, Moore RH, Jurewicz WA, Lord RH, Webley Y, Jenkins J.
Griffin PJ, et al. Among authors: webley y.
Transplant Proc. 1997 Feb-Mar;29(1-2):303. doi: 10.1016/s0041-1345(96)00118-2.
Transplant Proc. 1997.
PMID: 9123007
No abstract available.
Item in Clipboard
Cite
Cite